Claude Maraoui
President & CEO at Journey Medical Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Journey Medical Corporation, 3 years.
Journey Medical Corporation
Director · President & CEO
Chief executive roles
Journey Medical Corporation
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 22, 2026 | Journey Medical Corporation | Grant or award | +49,277 | — | — |
| Aug 25, 2025 | Journey Medical Corporation | Option exercise | +1,250,000 | $0.07 | $87,500 |
| Aug 25, 2025 | Journey Medical Corporation | Shares withheld for tax | −10,877 | $7.47 | $81,251 |
| Jun 17, 2025 | Journey Medical Corporation | Grant or award | +49,277 | — | — |
| May 2, 2025 | Journey Medical Corporation | Open-market sale | −4,834 | $6.84 | $33,065 |
| Mar 11, 2025 | Journey Medical Corporation | Open-market sale | −49,271 | $5.01 | $246,848 |
| Mar 7, 2025 | Journey Medical Corporation | Open-market sale | −14,905 | $5.01 | $74,674 |
| Mar 6, 2025 | Journey Medical Corporation | Open-market sale | −25,551 | $5.04 | $128,777 |
| Mar 5, 2025 | Journey Medical Corporation | Open-market sale | −18,147 | $5.13 | $93,094 |
| Mar 4, 2025 | Journey Medical Corporation | Open-market sale | −28,901 | $5.04 | $145,661 |
| Mar 3, 2025 | Journey Medical Corporation | Open-market sale | −23,508 | $5.19 | $122,007 |
| May 1, 2024 | Journey Medical Corporation | Grant or award | +175,000 | — | — |
| Mar 22, 2024 | Journey Medical Corporation | Open-market purchase | +10,000 | $3.48 | $34,800 |
| Jan 3, 2024 | Journey Medical Corporation | Grant or award | +175,000 | — | — |
| Sep 6, 2023 | Journey Medical Corporation | Open-market purchase | +26,044 | $2.52 | $65,631 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.